Cognition Therapeutics Inc Financial Flexibility Index
Cognition Therapeutics Inc financial flexibility index. Cognition Therapeutics Inc (CGTX) has a Financial Flexibility Index of -0.82x as of September 2025. Free cash flow of $-5.65 Million (operating CF $-5.65 Million minus capex $0.00) represents -1% of total liabilities ($6.87 Million). See CGTX FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Cognition Therapeutics Inc (2019–2024)
Financial flexibility index of Cognition Therapeutics Inc from 2019 to 2024. Historical Financial Flexibility Index trend for Cognition Therapeutics Inc across 6 annual periods. Check how high is Cognition Therapeutics Inc's earnings quality to evaluate the quality of earnings relative to operating cash generation.
Cognition Therapeutics Inc Financial Flexibility Index by Year (2019–2024)
Cognition Therapeutics Inc financial flexibility index by year from 2019 to 2024. Year-by-year free cash flow to debt coverage for Cognition Therapeutics Inc. For the full cash flow conversion analysis, see CGTX cash flow metrics.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -2.48x | $-28.47 Million | $-28.47 Million | $11.48 Million | ▼ -67.0% |
| 2023 | -1.48x | $-15.87 Million | $-16.02 Million | $10.69 Million | ▲ +17.7% |
| 2022 | -1.80x | $-18.36 Million | $-18.53 Million | $10.18 Million | ▼ -293.7% |
| 2021 | -0.46x | $-3.60 Million | $-3.63 Million | $7.86 Million | ▼ -908.2% |
| 2020 | -0.05x | $-3.42 Million | $-3.43 Million | $75.30 Million | ▼ -1.4% |
| 2019 | -0.04x | $-2.95 Million | $-3.10 Million | $65.88 Million | — |